Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101

Excision BioTherapeutics

Status and phase: Invitation-only; Phase 1

Conditions: HIV-1-infection

Treatments: Biological: EBT-101

Study type: Interventional

Funder types: Industry

Identifiers

NCT05143307

EBT-101-002

Details and patient eligibility

About

Participants who receive EBT-101 in a parent protocol will be eligible to participate in this long-term follow-up (LTFU) study (EBT-101-002).

Full description

Participants who receive EBT-101 in a parent protocol will be eligible to participate in this LTFU study (EBT-101-002). All participants will have follow-up visits every six months until Year 5 post EBT-101. Thereafter, all participants will have follow-up visits annually on the anniversary of EBT-101 administration until study completion at Year 15.

Enrollment: 9 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Willing and able to provide written, signed informed consent
• Participants who received the investigational study intervention EBT-101 in a parent study

Exclusion criteria

• Participants who did not receive EBT-101 in a parent study

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

9 participants in 1 patient group

Long Term Follow Up

Experimental group

Description:

Participants who received EBT-101 in a parent study will undergo long term follow up

Treatment:

Biological: EBT-101